🔎 Trials Near Me

홈 › 방광암 › 매사추세츠

매사추세츠의 방광암 임상 시험

방광암 관련 연구 32개가 매사추세츠 내 여러 지역에서 참여자를 모집하고 있습니다.

매사추세츠의 도시

공식 연구 텍스트(영어)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Lahey Clinic, Burlington
  • Lahey Clinic Peabody, Peabody
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT03866382

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

  • Tufts Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
  • UMass Memorial Medical Center - University Campus, Worcester
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07061964

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

  • Massachusetts General Hospital Cancer Center, Boston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06770582

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

  • Dana Farber Cancer Institute ( Site 0783), Boston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07419295

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • Massachusetts General Hospital, Boston
  • University of Massachusetts Medical School, Worcester
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07218380

Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy

  • Dana Farber Cancer Institute, Boston
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT07548476

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • Massachusetts General Hospital, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06465069

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

  • Dana-Farber Cancer Institute, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06644755

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
  • Dana-Farber Cancer Institute - Chestnut Hill, Newton
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07090499

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

  • Brigham and Women's Hospital, Boston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06567743

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • Dana-Farber Cancer Institute - Oncology Department, Boston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06760819

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

  • Brigham and Women's Hospital, Boston
  • Greater Boston Urology, LLC, Plymouth
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT05951179

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

  • Massachusetts General Hospital, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT05614739

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

  • Massachusetts General Hospital Cancer Center, Boston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT07097142

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • Massachusetts General Hospital Cancer Center, Boston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT05592626

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

  • Brigham and Women's Hospital, Boston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT04752722

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

  • Brigham and Women's Hospital, Boston
  • Lahey Clinic, Burlington
  • Lahey Clinic Peabody, Peabody
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT07000084

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

  • Local Institution - 0195, Boston
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT07106762

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Tufts Medical Center, Boston
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
피험자 모집 중2상
8세 이상 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT05503797

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

  • UMass Memorial Medical Center, Worcester
  • University of Massachusetts Chan Medical School, Worcester
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT04879329

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

  • Research Site, Boston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT07720284

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  • Massachusetts General Hospital, Boston
  • Brigham & Women's Hospital, Boston
  • Beth Israel Deaconess Medical Center,East Campus Research Pharmacy, Boston
  • 외 3개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT04389632

Integrated Cancer Repository for Cancer Research

  • Holyoke Medical Center, Holyoke
피험자 모집 중관찰 연구건강한 지원자 환영
19세 ~ 110세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT02012699

Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

  • Dana-Farber Cancer Institute, Boston
피험자 모집 중관찰 연구
65세 이상 · 모든 성별 · 2026. 2. 17. 업데이트됨 · NCT06138561

CONFIRM: Magnetic Resonance Guided Radiation Therapy

  • Brigham & Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 2. 9. 업데이트됨 · NCT04368702

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer

  • Lahey Clinic, Inc., Burlington
피험자 모집 중관찰 연구건강한 지원자 환영
18세 이상 · 모든 성별 · 2025. 12. 8. 업데이트됨 · NCT00872495

Sacituzumab Govitecan Plus EV in Metastatic UC

  • Dana Farber Cancer Institute, Boston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 11. 4. 업데이트됨 · NCT04724018

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Worcester
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

  • Harvard School of Medicine/Massachusetts General Hospital (MGH), Boston
피험자 모집 중
18세 이상 · 모든 성별 · 2025. 8. 14. 업데이트됨 · NCT04442724

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest

  • Brigham and Women's Hospital, Boston
피험자 모집 중
18세 이상 · 모든 성별 · 2023. 10. 24. 업데이트됨 · NCT05899361

Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

  • Brigham and Women's Hospital, Boston
피험자 모집 중3상
18세 ~ 85세 · 모든 성별 · 2023. 9. 28. 업데이트됨 · NCT03216525

Patient-Centered Surgical Prehabilitation

  • Brigham and Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
피험자 모집 중건강한 지원자 환영
18세 ~ 85세 · 모든 성별 · 2023. 3. 22. 업데이트됨 · NCT05715684

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.